A new analysis of nearly 900 obesity patients shows that men and women face distinctly different health hazards from excess weight, suggesting doctors should tailor treatment approaches based on sex rather than applying one-size-fits-all strategies.
Researchers at Dokuz Eylul University in Turkey examined 886 women and 248 men seeking treatment at an obesity clinic and found striking patterns in how their bodies respond to weight gain. Men tend to accumulate fat around their internal organs, a particularly dangerous type called visceral fat that wraps around the liver, pancreas, and other vital organs. Women, meanwhile, develop higher cholesterol and widespread inflammation throughout their bodies. Both pathways lead to serious complications, but the starting points differ fundamentally.
The gap showed up clearly in the data. Despite having nearly identical body mass indexes, men had waist circumferences about 12 centimeters larger than women and elevated liver enzyme levels suggesting potential organ damage. Women displayed higher total and LDL cholesterol alongside inflammatory markers like C-reactive protein that signal immune system activity gone awry.
Dr. Zeynep Pekel, who led the research presented at the European Congress on Obesity this spring, emphasized that these findings point to a critical oversight in modern medicine. "Sex differences are a powerful player in how obesity develops and progresses," Pekel said. "This could be a stepping stone toward finding targeted therapies specific to men and women."
The biological explanations trace back to hormones and genetics. Estrogen influences where women's bodies store fat and how their immune systems respond, often resulting in more subcutaneous fat just beneath the skin alongside heightened inflammatory activity. The X chromosome also plays a role in immune function. Men's bodies preferentially deposit fat around organs, creating metabolic stress that damages the liver and disrupts glucose processing.
The timing of this research matters. In 2023, roughly 1.54 billion adults worldwide had metabolic syndrome, a cluster of conditions including obesity, high blood pressure, and elevated cholesterol that dramatically increases heart disease and diabetes risk. That translates to about one in three women and one in four men dealing with this constellation of problems simultaneously.
The study involved comprehensive evaluations including blood tests, physical measurements, and assessments of liver function, kidney health, and inflammation markers. Participants averaged 45 years old for women and 41 for men, though most were of Turkish descent, which means the findings may not apply uniformly across different populations.
Researchers acknowledged significant limitations. Because the study captured patients at a single point in time rather than following them over years, it cannot establish cause and effect. Larger, more diverse studies across different ethnic groups will be essential to confirm whether these patterns hold universally.
Still, the implications are substantial for clinical practice. A man showing rising liver enzymes and expanding waistline might benefit most from interventions targeting metabolic dysfunction and organ fat reduction. A woman with elevated cholesterol and inflammatory markers might need approaches emphasizing anti-inflammatory strategies and lipid management. Generic obesity treatments ignore these biological realities.
Pekel signaled that the next phase of research will validate these findings in larger populations and dig deeper into the mechanisms driving sex-based differences. Understanding precisely how hormones, immune responses, and fat distribution interact could unlock more effective treatment plans.
Author Jessica Williams: "If obesity hits men and women in completely different ways, why are we still prescribing the same treatment playbook to both? This research suggests personalized medicine isn't a luxury in obesity care, it's a necessity."
Comments